ORCID

We notice you are using a browser that our site does not support. Some features on this site may not work correctly. We recommend that you upgrade to a supported browser.

Activities

Collapse all

PROMOTE-FL: Pirtobrutinib-Mosunetuzumab Enhancing Efficacy in Previously Treated Follicular Lymphoma

2025-04-01 to 2027-10-31 | Grant

Lymphoma Research Foundation (New York, US)

GRANT_NUMBER:

1373626

Show more detail

Source:

check_circle

ProposalCentral

How many people are using ORCID?